drugset / Trial / NCT00173901

Adverse Drug Reactions of Different Brands of Ceftazidime Injection

NCT00173901

Phase 4 Unknown 536 enrolled National Taiwan University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Timeline

Start
2001-03
Primary completion
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftazidime Small molecule

Indications